The Children's Medical Safety Research Institute is excited to announce its support for research into a groundbreaking treatment option for Alzheimer's disease.
Recent research reveals that the consumption of silicon-rich water can improve the memory and cognitive ability of individuals with early stage Alzheimer's disease. Silicon is known for its ability to extract aluminum from the body; this research therefore strongly suggests that aluminum plays a causal role in the onset of Alzheimer's disease. This is the only proposed treatment option within the last 40 years that has been shown to decrease or alter the progression of Alzheimer's disease.
Today, 44 million individuals around the world suffer from Alzheimer's disease. This number has increased with each passing decade, just as our exposure to the toxic element aluminum has increased. Aluminum is known to increase an individual's risk for a range of autoimmune diseases including lupus, rheumatoid arthritis, type 1 diabetes, and Alzheimer's disease. We are exposed to aluminum via the foods we eat, the products we use, and the vaccines we receive. (Be sure to download our free guide to reducing aluminum in your life.) Extensive research from leading scientists around the world has confirmed the dangers of aluminum; unfortunately, although the FDA has deemed aluminum a "toxin for the human nervous system, immune system and genetic system," little has been done to reduce human exposure.
The Children's Medical Safety Research Institute proudly supports efforts to conduct a more extensive clinical trial of a silicon-rich water treatment for Alzheimer's, to be conducted by leading aluminum researcher Professor Christopher Exley of Keele University. The crowd-funding project, "The People's Trial," has been established to raise money for this research. We are excited to support this fund and raise awareness of this promising area of research. Read our full article on this groundbreaking discovery and the "People's Trial" fund here.